Health Related Quality of Life of Youth and Young Adults With Haemophilia A
Status:
Recruiting
Trial end date:
2022-11-15
Target enrollment:
Participant gender:
Summary
Research question:
Whether there are the changes in quality of life in patients with haemophilia A after
switching from SHL FVIII prophylaxis to efmoroctocog alfa prophylaxis?
A 12-month prospective open-label, single-arm multicentre study. Evaluation of parameters
will be carried out on the backdrop of patient treatment in the settings of routine medical
practice. No medical examinations/ procedures/ treatment(s) on the top of regular medical
practice are planned, except fixed time of examinations.